UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 3,307 Shares of Transcat, Inc. (NASDAQ:TRNS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 24.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,029 shares of the scientific and technical instruments company's stock after buying an additional 3,307 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.18% of Transcat worth $1,801,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Jones Financial Companies Lllp lifted its position in Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock valued at $37,000 after purchasing an additional 309 shares during the period. Aquatic Capital Management LLC raised its position in shares of Transcat by 1,052.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after purchasing an additional 1,052 shares during the last quarter. Morgan Dempsey Capital Management LLC purchased a new stake in Transcat during the 4th quarter valued at about $143,000. SG Americas Securities LLC purchased a new stake in Transcat during the 4th quarter valued at about $182,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in Transcat during the 4th quarter valued at about $190,000. 98.34% of the stock is owned by hedge funds and other institutional investors.

Transcat Stock Performance

Shares of TRNS stock traded up $0.66 during trading hours on Wednesday, reaching $75.56. The stock had a trading volume of 238,000 shares, compared to its average volume of 85,709. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12. The firm has a 50-day simple moving average of $82.28 and a 200-day simple moving average of $87.67. The firm has a market capitalization of $704.07 million, a PE ratio of 40.84 and a beta of 0.75.

Transcat (NASDAQ:TRNS - Get Free Report) last announced its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.66 by ($0.02). The firm had revenue of $77.13 million during the quarter, compared to analyst estimates of $76.40 million. Transcat had a return on equity of 7.23% and a net margin of 6.22%. The company's revenue for the quarter was up 8.8% compared to the same quarter last year. As a group, equities analysts forecast that Transcat, Inc. will post 2.3 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on TRNS shares. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a research report on Wednesday, May 28th. HC Wainwright reaffirmed a "buy" rating and set a $116.00 price objective (up previously from $106.00) on shares of Transcat in a research report on Wednesday, May 21st. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Transcat currently has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.